Intended for menopausal symptoms to manage hormonal balance and support bone health.
Mechanism of Action
This medication replaces the naturally occurring hormone estradiol. It regulates gene transcription in target tissues to alleviate hot flashes and vaginal dryness while maintaining bone density in postmenopausal women.
Route of Administration
Oral
Onset Time
1–2 weeks
Duration
24 hours
Contraindications
History of thromboembolic disorders, Breast cancer, Undiagnosed uterine bleeding, Pregnancy
Severe Adverse Events
Venous thromboembolism, Stroke, Endometrial cancer — requires immediate medical attention
Common Side Effects
Nausea, Breast tenderness, Headache
Uncommon Side Effects
Weight changes, Mood fluctuations, Edema
Drug Interactions
Alcohol, Tobacco, Rifampin, St. John's Wort, Warfarin
Pregnancy Safety Warnings
FDA Category X: Strictly contraindicated in pregnancy. Breastfeeding: Excreted in milk; monitor infant.
Age Restrictions
Safety and efficacy established in pediatric patients for specific conditions.
Information related to Estradiol is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
